Keywords
How to Cite
Abstract
This thesis examines the impact of psychoemotional state on quality of life in patients with malignant tumors of the reproductive system receiving chemotherapy. An oncological diagnosis, the duration of treatment, side effects of chemotherapy, anxiety regarding disease prognosis, and changes in physical condition can significantly affect patients’ psychological well-being and daily activities. The study analyzes the relationship between anxiety, depressive symptoms, emotional distress, psychological adjustment, and quality-of-life indicators. It also evaluates the impact of psychoemotional state on patients’ physical activity, social relationships, adaptation to treatment, and overall life satisfaction. The findings are of practical importance for the early identification of the need for psychological and psychiatric support among patients with malignant tumors of the reproductive system, improving the effectiveness of comprehensive treatment, and enhancing quality of life.
References
1. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica. 1983;67(6):361–370.
2. Aaronson N.K., Ahmedzai S., Bergman B. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 1993;85(5):365–376.
3. Holland J.C., Breitbart W.S., Jacobsen P.B., Loscalzo M.J., McCorkle R., Butow P.N. Psycho-Oncology. 3rd ed. Oxford University Press, 2015.
4. Mitchell A.J., Chan M., Bhatti H. et al. Prevalence of depression, anxiety and adjustment disorder in oncological, haematological and palliative-care settings: a meta-analysis. The Lancet Oncology. 2011;12(2):160–174.
5. Mehnert A., Brähler E., Faller H. et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. Journal of Clinical Oncology. 2014;32(31):3540–3546.
6. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Distress Management. NCCN.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. Washington, DC: American Psychiatric Association Publishing, 2022.